Skip to content
MS
rate-limiting unreviewed

Aldose reductase (AKR1B1)

2 reactions · 2 pathways

Clinical / pharmacological. Target of aldose reductase inhibitors; polyol accumulation in diabetes

What it does, reaction by reaction

2 reactions

Galactose Metabolism Carbohydrate Metabolism · Cytosol

step 7 Irreversible/directional

Galactose + NADPH + H+ → galactitol + NADP+

Converts Galactose NADPH H+ into Galactitol NADP+

Notes

Aldose reductase reduces excess galactose to galactitol using NADPH. This is a side pathway rather than a normal energy-yielding Leloir step; galactitol is poorly metabolized and can accumulate, particularly in the lens.

Sorbitol / Polyol Pathway Carbohydrate Metabolism · Cytosol

step 1 Irreversible/directional rate-limiting

Glucose + NADPH + H+ -> sorbitol + NADP+

Converts Glucose NADPH H+ into Sorbitol NADP+

Notes

Rate-limiting. High Km for glucose, so flux rises sharply in hyperglycaemia. Also reduces galactose to galactitol.

Showing all 2 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

0 entries

No regulation recorded for this enzyme in the source documents.

Recent literature

Nothing is fetched until you ask, so the page stays fast and the request is yours rather than automatic.

Europe PMC · ten most recent, newest first